Lv3
240 积分 2024-05-28 加入
reciprocal assistance
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
12天前
已完结
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
1个月前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
1个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
1个月前
已完结
Advances and resistance adaptation in BTK-targeted therapy for B-cell malignancies
1个月前
已完结
Treatment of chronic cough: P2X3 receptor antagonists and beyond
1个月前
已完结
Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough
1个月前
已完结
The Clinical Approach to Chronic Cough
1个月前
已完结
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough
1个月前
已完结
Treatment of chronic cough: P2X3 receptor antagonists and beyond
1个月前
已完结
皖公网安备34019202002308
